Overview
MHRA oversees device conformity clinical investigations and postmarket vigilance for imaging modalities in the United Kingdom.
Modality Focus
Guidance covers CT MRI ultrasound mammography and nuclear medicine device safety and clinical investigation requirements.
Brexit Transition
MHRA has established UK specific regulatory pathways and guidance following EU transition.
Clinical Impact
Manufacturers and clinical users follow MHRA guidance for device placement and safety in UK imaging services.